IE810460L - Enzyme inhibitors. - Google Patents
Enzyme inhibitors.Info
- Publication number
- IE810460L IE810460L IE810460A IE46081A IE810460L IE 810460 L IE810460 L IE 810460L IE 810460 A IE810460 A IE 810460A IE 46081 A IE46081 A IE 46081A IE 810460 L IE810460 L IE 810460L
- Authority
- IE
- Ireland
- Prior art keywords
- lysyl
- tryptophyl
- cyclopentanecarbonyl
- dehydroproline
- isoleucyl
- Prior art date
Links
- 239000002532 enzyme inhibitor Substances 0.000 title 1
- -1 acetyl propanoyl Chemical group 0.000 abstract 12
- OMGHIGVFLOPEHJ-BYPYZUCNSA-N (2s)-2,5-dihydro-1h-pyrrole-2-carboxylic acid Chemical group OC(=O)[C@H]1NCC=C1 OMGHIGVFLOPEHJ-BYPYZUCNSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 abstract 1
- 125000000030 D-alanine group Chemical group [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 abstract 1
- 125000002437 D-histidyl group Chemical group N[C@@H](C(=O)*)CC=1N=CNC1 0.000 abstract 1
- 125000000249 D-isoleucyl group Chemical group N[C@@H](C(=O)*)[C@@H](CC)C 0.000 abstract 1
- 125000003301 D-leucyl group Chemical group N[C@@H](C(=O)*)CC(C)C 0.000 abstract 1
- 125000002436 D-phenylalanyl group Chemical group N[C@@H](C(=O)*)CC1=CC=CC=C1 0.000 abstract 1
- DZLNHFMRPBPULJ-GSVOUGTGSA-N D-thioproline Chemical compound OC(=O)[C@H]1CSCN1 DZLNHFMRPBPULJ-GSVOUGTGSA-N 0.000 abstract 1
- 125000002716 D-tryptophyl group Chemical group N[C@@H](C(=O)*)CC1=CNC2=CC=CC=C12 0.000 abstract 1
- 125000000240 D-tyrosyl group Chemical group N[C@@H](C(=O)*)CC1=CC=C(C=C1)O 0.000 abstract 1
- 125000003625 D-valyl group Chemical group N[C@@H](C(=O)*)C(C)C 0.000 abstract 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 abstract 1
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 abstract 1
- 125000002435 L-phenylalanyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 229930182821 L-proline Natural products 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 150000003949 imides Chemical class 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229960002429 proline Drugs 0.000 abstract 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Inhibitors of angiotensin converting enzyme which have the formula: <IMAGE> wherein R is hydrogen, formyl, acetyl propanoyl, butanoyl, phenylacetyl, phenylpropanoyl, benzoyl, cyclopentanecarbonyl, tert-butyloxycarbonyl, cyclopentanecarbonyl-L-lysyl, pyro-L-glutamyl-L-lysyl, L-lysyl, L-arginyl or pyro-L-glutamyl; A is L-phenylalanyl, D-phenylalanyl, D,L-alanyl, D-alanyl, D,L-tryptophyl, D-tryptophyl, D,L-tyrosyl, D-tyrosyl, D,L-isoleucyl, D-isoleucyl, D,L-leucyl, D-leucyl, D,L-histidyl, D-histidyl, D,L-valyl, or D-valyl, the alpha -amino group thereof being in amide linkage with R; R1 is hydrogen or methyl; R2 is L-proline, L-3,4-dehydroproline, D,L-3,4-dehydroproline, L-3-hydroxyproline, L-4-hydroxyproline, L-thiazolidine-4-carboxylic acid, or L-5-oxo-proline, the imino group thereof being in imide linkage with the adjacent <IMAGE> and, n is 0 or 1, such that when n is 0, R1 is methyl are disclosed as useful anti-hypertensive agents.
[US4692459A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/121,188 US4692459A (en) | 1979-08-14 | 1980-03-03 | Anti-hypertensive agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE810460L true IE810460L (en) | 1981-09-03 |
| IE51259B1 IE51259B1 (en) | 1986-11-26 |
Family
ID=22395126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE460/81A IE51259B1 (en) | 1980-03-03 | 1981-03-03 | Angiotensin converting enzyme inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4692459A (en) |
| EP (1) | EP0035383B1 (en) |
| JP (1) | JPS56164115A (en) |
| AT (1) | AT385038B (en) |
| AU (1) | AU534945B2 (en) |
| DD (1) | DD158238A5 (en) |
| DE (1) | DE3163812D1 (en) |
| DK (1) | DK93081A (en) |
| FI (1) | FI76558C (en) |
| IE (1) | IE51259B1 (en) |
| IL (1) | IL62203A (en) |
| NZ (1) | NZ194002A (en) |
| PL (1) | PL229971A1 (en) |
| PT (1) | PT70158A1 (en) |
| ZA (1) | ZA803486B (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692458A (en) * | 1980-03-05 | 1987-09-08 | University Of Miami | Anti-hypertensive agents |
| JPS57209270A (en) * | 1981-06-19 | 1982-12-22 | Chugai Pharmaceut Co Ltd | Proline derivative |
| FI850948A7 (en) * | 1984-03-12 | 1985-09-13 | Pfizer | Renin inhibitors that contain a statin or its derivatives. |
| US5187183A (en) * | 1988-06-15 | 1993-02-16 | Brigham & Women's Hospital | S-nitroso derivatives of ACE inhibitors and the use thereof |
| US5356890A (en) * | 1988-06-15 | 1994-10-18 | Brigham And Women's Hospital | S-nitroso derivatives of ace inhibitors and the use thereof |
| US5025001A (en) * | 1988-06-15 | 1991-06-18 | Brigham And Women's Hospital | S-nitroso derivatives of ACE inhibitors and the use thereof |
| DE4010797A1 (en) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | SUBSTITUTED AZOLES, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING THEM AND THE USE THEREOF |
| DE10115938A1 (en) * | 2001-03-30 | 2002-10-10 | Medigene Ag Ges Fuer Molekular | Process for the preparation of oxirane carboxylic acids and derivatives thereof |
| US9259535B2 (en) | 2006-06-22 | 2016-02-16 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
| US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
| US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
| US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
| CN103796704B (en) | 2011-07-12 | 2016-12-07 | 博讯瓦勒公司 | Device for delivering an antimicrobial agent into a percutaneous catheter |
| US10046156B2 (en) | 2014-05-02 | 2018-08-14 | Excelsior Medical Corporation | Strip package for antiseptic cap |
| EP3294404B1 (en) | 2015-05-08 | 2025-06-11 | ICU Medical, Inc. | Medical connectors configured to receive emitters of therapeutic agents |
| CA3243573A1 (en) | 2016-10-14 | 2025-06-12 | Icu Medical, Inc. | Sanitizing caps for medical connectors |
| WO2018204206A2 (en) | 2017-05-01 | 2018-11-08 | Icu Medical, Inc. | Medical fluid connectors and methods for providing additives in medical fluid lines |
| JP6600386B1 (en) * | 2018-07-06 | 2019-10-30 | Ｋｙｂ株式会社 | Valve device |
| US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
| US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
| US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
| US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
| US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
| CA3118905A1 (en) | 2018-11-21 | 2020-05-28 | Icu Medical, Inc. | Antimicrobial device comprising a cap with ring and insert |
| JP2024500319A (en) | 2020-12-07 | 2024-01-09 | アイシーユー・メディカル・インコーポレーテッド | Peritoneal dialysis cap, system, and method |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3947575A (en) * | 1969-06-30 | 1976-03-30 | E. R. Squibb & Sons, Inc. | Peptides as argiotensin converting enzyme inhibitors |
| US3832337A (en) * | 1970-07-28 | 1974-08-27 | Squibb & Sons Inc | Peptide enzyme inhibitors |
| US3891616A (en) * | 1974-04-17 | 1975-06-24 | Squibb & Sons Inc | Hypotensive {62 -homoaminoacid nonapeptides |
| US4052511A (en) * | 1976-02-13 | 1977-10-04 | E. R. Squibb & Sons, Inc. | Carboxyacylproline derivatives |
| US4046889A (en) * | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
| US4053651A (en) * | 1976-05-10 | 1977-10-11 | E. R. Squibb & Sons, Inc. | Compounds and method for alleviating angiotensin related hypertension |
| US4113715A (en) * | 1977-01-17 | 1978-09-12 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
| GR73585B (en) * | 1978-09-11 | 1984-03-26 | Univ Miami |
-
1979
- 1979-09-10 PT PT70158A patent/PT70158A1/en unknown
-
1980
- 1980-03-03 US US06/121,188 patent/US4692459A/en not_active Expired - Lifetime
- 1980-06-11 ZA ZA00803486A patent/ZA803486B/en unknown
- 1980-06-11 NZ NZ194002A patent/NZ194002A/en unknown
- 1980-06-11 AU AU59227/80A patent/AU534945B2/en not_active Ceased
-
1981
- 1981-02-24 IL IL62203A patent/IL62203A/en unknown
- 1981-02-27 DE DE8181300825T patent/DE3163812D1/en not_active Expired
- 1981-02-27 EP EP81300825A patent/EP0035383B1/en not_active Expired
- 1981-03-02 AT AT0097081A patent/AT385038B/en not_active IP Right Cessation
- 1981-03-02 DK DK93081A patent/DK93081A/en not_active Application Discontinuation
- 1981-03-03 PL PL22997181A patent/PL229971A1/xx unknown
- 1981-03-03 FI FI810663A patent/FI76558C/en not_active IP Right Cessation
- 1981-03-03 DD DD81228014A patent/DD158238A5/en not_active IP Right Cessation
- 1981-03-03 IE IE460/81A patent/IE51259B1/en unknown
- 1981-03-03 JP JP3042981A patent/JPS56164115A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| AU5922780A (en) | 1981-09-10 |
| FI76558B (en) | 1988-07-29 |
| DK93081A (en) | 1981-09-04 |
| DE3163812D1 (en) | 1984-07-05 |
| JPH03386B2 (en) | 1991-01-07 |
| ZA803486B (en) | 1981-06-24 |
| EP0035383B1 (en) | 1984-05-30 |
| ATA97081A (en) | 1987-07-15 |
| FI76558C (en) | 1988-11-10 |
| EP0035383A1 (en) | 1981-09-09 |
| FI810663L (en) | 1981-09-04 |
| US4692459A (en) | 1987-09-15 |
| PL229971A1 (en) | 1982-02-01 |
| IL62203A (en) | 1984-07-31 |
| IE51259B1 (en) | 1986-11-26 |
| DD158238A5 (en) | 1983-01-05 |
| PT70158A1 (en) | 1982-03-01 |
| JPS56164115A (en) | 1981-12-17 |
| AT385038B (en) | 1988-02-10 |
| AU534945B2 (en) | 1984-02-23 |
| NZ194002A (en) | 1982-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE810460L (en) | Enzyme inhibitors. | |
| MY129227A (en) | Method for increasing bone toughness and stiffness | |
| DE69432758D1 (en) | Therapeutisch wirksame peptidderivate | |
| PE20000560A1 (en) | USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C | |
| AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
| WO2002048183A3 (en) | Compositions of peptide crystals | |
| AU2905092A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| DE69818987D1 (en) | COMPOSITION AND METHOD FOR DELAYING TRANSPORT BY BIOLOGICAL MEMBRANES | |
| LU91857I2 (en) | Abarelix, optionally in pharmaceutically acceptable salt form | |
| AU3651802A (en) | Recombinant anti-cd30 antibodies and uses thereof | |
| MX9705954A (en) | Formulations and methods for reducing skin irritation. | |
| UA41446C2 (en) | Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition | |
| AU3780901A (en) | Pharmaceutical composition for muscular anabolism | |
| WO2002024883A3 (en) | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions | |
| TR200103149T2 (en) | Methods for protection of virus and mycoplasma | |
| HUT74431A (en) | Pharmaceutical composition to the blocking the accumulation of germs on human cells | |
| AU3855297A (en) | Pharmaceutical composition for treating papillomavirus tumours and infection | |
| IT1299583B1 (en) | USE OF HMG-I PROTEIN FOR THE PREPARATION OF MEDICATIONS WITH CYTOTOXIC ACTIVITY | |
| EP1066811A3 (en) | Absorbent article | |
| AU2420001A (en) | Methods and compositions for the treatment of pain | |
| WO2000006750A3 (en) | Method for autoactivation of procaspase 8 | |
| IE882408L (en) | Promoting absorption of peptides and proteins at the musosa¹by means of cyclic peptides | |
| CA2263184A1 (en) | Methods and compositions for increasing the anaerobic working capacity in tissues | |
| AU2566101A (en) | Compounds and methods for the treatment of pain | |
| WO1996032134A3 (en) | Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |